NCT02429102View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Healthy
Interventions
DRUG

MT-8554

DRUG

Placebo

Trial Locations (1)

Unknown

Investigational center, City Name

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY